2.
Univariable analysis and Cox proportional hazards regression analysis for all patients
| Variables | Number | Univariable analysis | Multivariable analysis | |||
| P | HR (95% CI) | P | β | |||
| M, male; F, female; PS, performance status; CEA, baseline carcinoembryonic antigen; CA19-9, baseline carbohydrate antigen 19-9; T4b, tumor invading the organs nearby; ORR, objective response rate; HR, hazard ratio; 95% CI, 95% confidence interval; β, β regression coefficients. | ||||||
| Age (years) | 0.168 | |||||
| ≥65 | 15 | |||||
| <65 | 80 | |||||
| Sex ratio (M:F) | 67:28 | 0.016 | ||||
| PS | 0.018 | |||||
| ≥2 | 8 | |||||
| <2 | 87 | |||||
| Tumor size (cm) | 0.050 | |||||
| ≥7 | 36 | |||||
| <7 | 50 | |||||
| Tumor location | 0.017 | |||||
| Cardia | 36 | |||||
| Noncardia | 59 | |||||
| Tumor differentiation | 0.001 | |||||
| Poorly differentiated | 74 | |||||
| Moderately/well-differentiated | 21 | |||||
| CEA (ng/mL) | 0.741 | |||||
| ≥5 | 39 | |||||
| <5 | 46 | |||||
| CA19-9 (U/mL) | 0.018 | |||||
| ≥35 | 38 | |||||
| <35 | 45 | |||||
| Peritoneal seeding | 0.013 | 0.050 | 0.297 | |||
| Yes | 27 | 1.35 (1.00−1.82) | ||||
| No | 68 | Reference | ||||
| T4b | 0.280 | |||||
| Yes | 17 | |||||
| No | 78 | |||||
| Ascites | <0.001 | <0.001 | 0.505 | |||
| Yes | 17 | 1.66 (1.25−2.21) | ||||
| No | 78 | Reference | ||||
| No. of noncurative factors | <0.001 | <0.001 | 0.952 | |||
| 1 | 48 | Reference | ||||
| ≥2 | 47 | 2.59 (1.77−3.80) | ||||
| Chemotherapy response | <0.001 | 0.421 | ||||
| ORR | 61 | <0.001 | Reference | |||
| Without ORR | 34 | 1.52 (1.19−1.95) | ||||